Literature DB >> 26824221

Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin.

Jared Klarquist1, Jonathan M Eby1, Steven W Henning1, Mingli Li2, Derek A Wainwright1, Wiete Westerhof3, Rosalie M Luiten3, Michael I Nishimura1,4, I Caroline Le Poole1,5.   

Abstract

We isolated gp100-reactive T cells from perilesional skin of a patient with progressive vitiligo with superior reactivity toward melanoma cells compared with tumor-infiltrating lymphocytes 1520, a melanoma-derived T-cell line reactive with the same cognate peptide. After dimer enrichment and limited dilution cloning, amplified cells were subjected to reverse transcription and 5' RACE to identify the variable TCRα and TCRβ subunit sequences. The full-length sequence was cloned into a retroviral vector separating both subunits by a P2A slippage sequence and introduced into Jurkat cells and primary T cells. Cytokine secreted by transduced cells in response to cognate peptide and gp100-expressing targets signifies that we have successfully cloned a gp100-reactive T-cell receptor from actively depigmenting skin.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  T cell receptor; melanoma; vitiligo

Mesh:

Substances:

Year:  2016        PMID: 26824221      PMCID: PMC6095469          DOI: 10.1111/pcmr.12458

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  21 in total

1.  Next-generation DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation.

Authors:  Ying Jin; Tracey Ferrara; Katherine Gowan; Cherie Holcomb; Melinda Rastrou; Henry A Erlich; Pamela R Fain; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2012-03-08       Impact factor: 8.551

2.  Accumulation of identical T cells in melanoma and vitiligo-like leukoderma.

Authors:  J C Becker; P Guldberg; J Zeuthen; E B Bröcker; P T Straten
Journal:  J Invest Dermatol       Date:  1999-12       Impact factor: 8.551

3.  Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.

Authors:  I C Le Poole; R M van den Wijngaard; W Westerhof; P K Das
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

Review 4.  Vitiligo. It is important.

Authors:  J J Nordlund; A B Lerner
Journal:  Arch Dermatol       Date:  1982-01

Review 5.  Therapeutic implications of autoimmune vitiligo T cells.

Authors:  Kepa Oyarbide-Valencia; Jasper G van den Boorn; Cecele J Denman; Mingli Li; Jeremy M Carlson; Claudia Hernandez; Michael I Nishimura; Pranab K Das; Rosalie M Luiten; I Caroline Le Poole
Journal:  Autoimmun Rev       Date:  2006-05-06       Impact factor: 9.754

6.  Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma.

Authors:  Katelyn T Byrne; Anik L Côté; Peisheng Zhang; Shannon M Steinberg; Yanxia Guo; Rameeza Allie; Weijun Zhang; Marc S Ernstoff; Edward J Usherwood; Mary Jo Turk
Journal:  J Clin Invest       Date:  2011-04-11       Impact factor: 14.808

Review 7.  T-cell engineering for cancer immunotherapy.

Authors:  Michel Sadelain
Journal:  Cancer J       Date:  2009 Nov-Dec       Impact factor: 3.360

Review 8.  T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity.

Authors:  Jennifer D Stone; Adam S Chervin; David M Kranz
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

9.  Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.

Authors:  Tamson V Moore; Gretchen E Lyons; Natasha Brasic; Jeffrey J Roszkowski; Simon Voelkl; Andreas Mackensen; W Martin Kast; I Caroline Le Poole; Michael I Nishimura
Journal:  Cancer Immunol Immunother       Date:  2008-10-03       Impact factor: 6.968

10.  T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse.

Authors:  Amy E Moran; Keli L Holzapfel; Yan Xing; Nicole R Cunningham; Jonathan S Maltzman; Jennifer Punt; Kristin A Hogquist
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

View more
  7 in total

Review 1.  The convergence theory for vitiligo: A reappraisal.

Authors:  Roopal V Kundu; Julia M Mhlaba; Stephanie M Rangel; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2018-06-28       Impact factor: 3.960

2.  Adoptive T-Cell Transfer to Treat Lymphangioleiomyomatosis.

Authors:  Fei Han; Emilia R Dellacecca; Levi W Barse; Cormac Cosgrove; Steven W Henning; Christian M Ankney; Dinesh Jaishankar; Alexander Yemelyanov; Vera P Krymskaya; Daniel F Dilling; I Caroline Le Poole
Journal:  Am J Respir Cell Mol Biol       Date:  2020-06       Impact factor: 6.914

3.  Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cells.

Authors:  Jonathan M Eby; Angela R Smith; Timothy P Riley; Cormac Cosgrove; Christian M Ankney; Steven W Henning; Chrystal M Paulos; Elizabeth Garrett-Mayer; Rosalie M Luiten; Michael I Nishimura; Brian M Baker; I Caroline Le Poole
Journal:  Pigment Cell Melanoma Res       Date:  2018-08-13       Impact factor: 4.693

4.  Tumor rejection properties of gp100209-specific T cells correlate with T cell receptor binding affinity towards the wild type rather than anchor-modified antigen.

Authors:  Jesus A Alonso; Angela R Smith; Brian M Baker
Journal:  Mol Immunol       Date:  2021-05-11       Impact factor: 4.174

Review 5.  Myron Gordon Award paper: Microbes, T-cell diversity and pigmentation.

Authors:  I Caroline Le Poole
Journal:  Pigment Cell Melanoma Res       Date:  2021-01-27       Impact factor: 4.159

6.  MicroRNA‑155 inhibits the proliferation of CD8+ T cells via upregulating regulatory T cells in vitiligo.

Authors:  Mingfen Lv; Zhengjun Li; Jingjing Liu; Fan Lin; Qianwen Zhang; Zhiming Li; Yi Wang; Keyu Wang; Yunsheng Xu
Journal:  Mol Med Rep       Date:  2019-08-23       Impact factor: 2.952

Review 7.  The Role of MicroRNAs in Vitiligo: Regulators and Therapeutic Targets.

Authors:  Lili Li
Journal:  Ann Dermatol       Date:  2020-11-11       Impact factor: 1.444

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.